For the quarter ending 2025-09-30, AGL made $1,435,321,000 in revenue. -$110,207,000 in net income. Net profit margin of -7.68%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenues | 1,435,321,000 | 1,394,982,000 | 1,532,782,000 | 1,557,012,500 |
| Expenses-Medical Services | 1,489,479,000 | 1,445,245,000 | - | - |
| Expenses | - | - | 1,482,060,000 | 1,442,998,500 |
| Expenses-Other Operating | 13,488,000 | 2,164,000 | - | - |
| Impairments | - | - | - | 899,000 |
| General and administrative | 56,198,000 | 56,281,000 | 65,956,000 | 177,400,000 |
| Depreciation and amortization | 7,430,000 | 7,319,000 | 6,876,000 | 6,169,000 |
| Total expenses | 1,566,595,000 | 1,511,009,000 | 1,554,892,000 | 1,627,466,500 |
| Income (loss) from operations | -131,274,000 | -116,027,000 | -22,110,000 | -57,639,000 |
| Income (loss) from equity method investments | 13,133,000 | 5,412,000 | 12,672,000 | 1,495,000 |
| Other income (expense), net | 9,441,000 | 7,879,000 | 9,261,000 | 6,793,500 |
| Interest expense | 1,838,000 | 1,572,000 | 1,515,000 | 1,429,000 |
| Income (loss) before income taxes | -110,538,000 | -104,308,000 | -1,692,000 | -50,779,500 |
| Income tax benefit (expense) | -331,000 | 62,000 | 196,000 | 812,000 |
| Income (loss) from continuing operations | -110,207,000 | -104,370,000 | -1,888,000 | -51,591,500 |
| Income (loss) before gain (loss) on sales | 0 | 0 | - | - |
| Adjustments on sale of assets, net | 0 | 0 | 14,000,000 | -2,190,750 |
| Income (loss) before gain (loss) on sales and income taxes | - | - | - | -265,250 |
| Total discontinued operations | 0 | 0 | 14,000,000 | -2,456,000 |
| Net income (loss) | -110,207,000 | -104,370,000 | 12,112,000 | -55,912,000 |
| Noncontrolling interests share in (earnings) loss | 0 | 0 | - | 10,000 |
| Net income (loss) attributable to common shares | -110,207,000 | -104,370,000 | 12,112,000 | -55,927,000 |
| Weighted average shares outstanding basic (in shares) | 414,465,000 | 413,836,000 | 412,936,000 | -205,948,000 |
| Weighted average shares outstanding diluted (in shares) | 414,465,000 | 413,836,000 | 412,936,000 | -205,948,000 |
agilon health, inc. (AGL)
agilon health, inc. (AGL)